Journal article
Adjunctive Therapy in Community-Acquired Pneumonia
Abstract
Despite potent antibiotics, community-acquired pneumonia (CAP) remains the most common cause of death from infection and the eighth overall leading cause of death in the United States. For this reason, adjunctive therapeutic measures directed at the host response rather than the pathogen are attractive. The immunomodulatory effects of macrolide antibiotics may play a significant role in management of severe CAP. The existing literature does not …
Authors
Wunderink R; Mandell L
Journal
Seminars in Respiratory and Critical Care Medicine, Vol. 33, No. 03, pp. 311–318
Publisher
Thieme
Publication Date
June 2012
DOI
10.1055/s-0032-1315643
ISSN
1069-3424